FDA Advisors Vote Against Two Drugs for Menopausal Hot Flashes

Reuters, March 5, 2013. Advisers to the Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause. “The FDA’s advisors did a great job today of carefully considering the scientific evidence,” said Diana Zuckerman, president of the National Research Center for Women & Families.

Read More »

Perfecting Bodies Through Chemistry?

Fem2.0, February 22, 2013. In the U.S., there are thousands of products and procedures that feed on women’s insecurities. While most are ineffective, only a few are actually dangerous to our health. Breast implants are one of those.

Read More »

Hip Implants a Bit More Likely to Fail in Women

Associated Press, February 18, 2013. A new study reports that hip replacements are slightly more likely to fail in women than in men. Dr. Zuckerman states, “this is the first step in what has to be a much longer-term strategy to figure out why women have worse experiences.”

Read More »

Study Suggests Women Have Higher Risk of Hip Implant Failure

The JAMA Network, February 18, 2013. A study in JAMA shows that women have a higher risk of implant failure than men following total hip replacement. In a commentary, NRC President Diana Zuckerman stresses that long-term comparative effectiveness data would enable patients and their physicians to choose the hip devices and surgical techniques that are most likely to be successful for a longer period.

Read More »

Antibiotics: When Science and Wishful Thinking Collide

Health Affairs Blog, January 25, 2013. Antibiotic resistance is a major concern confronting our health care system, and there is tremendous pressure on the Food and Drug Administration (FDA) to “do something” about it. Unfortunately, the FDA is responding by approving drugs that are likely to do more harm than good.

Read More »